Your session is about to expire
← Back to Search
Corticosteroid
Budesonide irrigation for Chronic Sinusitis
Phase 3
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after beginning of treatment
Awards & highlights
Summary
This trial is testing whether a nasal spray or a nose irrigation is more effective for people with chronic sinus problems who have not had surgery.
Eligible Conditions
- Chronic Sinusitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months after beginning of treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after beginning of treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Disease specific quality of life questionnaire
Secondary study objectives
Endoscopic evaluation of the nasal cavities
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Budesonide irrigationExperimental Treatment1 Intervention
2 cc budesonide nebule (0,5 mg/cc) incorporated to 240 of saline water (Sinus Rinse) to be taken on a daily basis x 3 months
Group II: Mometasone nasal sprayActive Control1 Intervention
Mometasone nasal spray 50 mcg/dose, 2 sprays/nostril twice daily x 3 months Patients will also be taking Sinus Rinse once daily throughout the study period
Find a Location
Who is running the clinical trial?
Université de SherbrookeLead Sponsor
302 Previous Clinical Trials
70,227 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger